Teppei Suzuki
Papers
1
Total Citations
27
H-Index
1
About
Dr. Teppei Suzuki is a leading urologic oncologist whose research focuses on the cost-effectiveness and comparative outcomes of surgical treatments for bladder cancer. His major contribution lies in pioneering systematic analyses of healthcare economics in urologic oncology, particularly through his landmark 2019 study comparing segmental costs across open, laparoscopic, and robot-assisted radical cystectomy. This work, cited 27 times, provides crucial evidence for hospital administrators and surgeons weighing the benefits of minimally invasive techniques against their higher procedural expenses. Dr. Suzuki’s research addresses a critical gap in the literature by moving beyond simple total cost comparisons to examine specific cost drivers—such as operative time, length of stay, and equipment—enabling more targeted strategies for cost containment without compromising patient outcomes. His work has significant implications for healthcare policy and resource allocation in an era of rising medical costs. Dr. Suzuki continues to influence clinical practice by helping institutions make evidence-based decisions about surgical approach selection for bladder cancer patients, balancing clinical efficacy with financial sustainability.
Research Focus
Key Achievements
Top Papers
- 1